Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Scaling the Unreachable: Acoustic Droplet Ejection for DNA-Encoded Library Multicomponent Synthesis

Project description

Accelerating drug discovery with DNA libraries

Drug discovery requires screening vast numbers of molecules against biological targets, a process that is costly, time-consuming and chemically limited with conventional methods. DNA-encoded libraries address this by attaching unique DNA barcodes to millions of compounds, enabling simultaneous screening at unprecedented scale. With the support of the Marie Skłodowska-Curie Actions programme, the ADES-DELi-MCR project transforms DNA-encoded library technology by integrating a precise, tip-free liquid handling method called acoustic droplet ejection with multicomponent chemical reactions. The idea is to generate structurally complex molecules in nanolitre volumes, reducing reagent consumption dramatically while expanding chemical diversity to billions of compounds. This sustainable high-throughput platform will be validated against both purified targets and cells, aiming to identify novel drug candidates across various diseases.

Objective

DNA-encoded libraries (DELs) allow the screening of millions to billions of small molecules via DNA barcodes that record each compound’s synthesis. Conventional DEL workflows rely on simple reactions (e.g. amide coupling, Suzuki) in microliter volumes using tip-based robots, limiting chemical diversity, sustainability, and throughput. This project overcomes these constraints by integrating acoustic droplet ejection (ADE), multicomponent reactions (MCRs), and DEL synthesis for the first time. ADE enables nanoliter-scale, tip-free transfers with high precision, drastically reducing reagent consumption and time. Coupled with MCR chemistry, such as Ugi-4CR, libraries of 10⁸–10⁹ structurally complex, 3D-rich molecules can be generated in hours under DNA-compatible conditions. The workflow includes ADE-based synthesis, enzymatic DNA ligation, and selection assays—achievable in a single afternoon. Biological validation will employ both target-based pull-down/NGS screening and proteome-wide selections in whole-cell lysates using covalent capture strategies. This dual approach ensures robust identification of ligands active in purified and complex systems. The CATRIN/IMTM Dömling lab offers unparalleled infrastructure, including advanced automation (Echo, TECAN EVO), UPLC-MS, NGS, and the world’s largest isocyanide collection, supported by expertise in synthetic chemistry, DEL screening, and MCR methodology. A provisional patent has been filed, and strong industrial interest underscores the platform’s commercial potential. This sustainable, high-throughput strategy redefines DEL synthesis, enabling AI-driven design loops and positioning Palacky University as a leader in next-generation drug discovery.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

UNIVERZITA PALACKEHO V OLOMOUCI
Net EU contribution
€ 215 907,93
Address
KRIZKOVSKEHO 8
771 47 Olomouc
Czechia
Region
Česko Střední Morava Olomoucký kraj
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (1)